Compile Data Set for Download or QSAR
maximum 50k data
Found 135 with Last Name = 'whalley' and Initial = 'dp'
TargetDiacylglycerol O-acyltransferase 1(Rattus norvegicus (rat))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385398(CHEMBL2036730)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of rat DGAT1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385398(CHEMBL2036730)
Affinity DataIC50:  0.5nMAssay Description:Inhibition of DGAT1-mediated triacylglycerol synthesis in human HuTu80 cellsMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385398(CHEMBL2036730)
Affinity DataIC50:  0.600nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Mus musculus (mouse))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385398(CHEMBL2036730)
Affinity DataIC50:  1.10nMAssay Description:Inhibition of mouse DGAT1More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24393(2,3-dichloro-N-{1-[(2R)-2,3-dihydroxypropyl]-2-oxo...)
Affinity DataIC50:  2nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385439(CHEMBL2036745)
Affinity DataIC50:  4.40nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194411((S)-2,3-dichloro-N-(1-(dimethylamino)-1-oxo-3-phen...)
Affinity DataIC50:  5nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385429(CHEMBL2036734)
Affinity DataIC50:  5.70nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385424(CHEMBL2036596)
Affinity DataIC50:  6.60nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385412(CHEMBL2036583)
Affinity DataIC50:  6.70nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24385(2,3-dichloro-N-[1-(2-hydroxyethyl)-2-oxo-1,2,3,4-t...)
Affinity DataIC50:  7nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194415(2,3-dichloro-N-((1R,2R)-1-hydroxy-2,3-dihydro-1H-i...)
Affinity DataIC50:  9nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24399(2-chloro-N-[(3S)-1-[(2S)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50:  12nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385425(CHEMBL2036597)
Affinity DataIC50:  13nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385415(CHEMBL2036586)
Affinity DataIC50:  16nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24387(3,4-dihydro-2-quinolone (DHQ) derivative, 26 | 5-c...)
Affinity DataIC50:  17nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320331((S)-2-((1R,2R)-2-(2,3-DICHLORO-4H-THIENO[3,2-B]PYR...)
Affinity DataIC50:  17nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194414((S)-2-chloro-N-(1-(dimethylamino)-1-oxo-3-phenylpr...)
Affinity DataIC50:  17nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320321(2-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  18nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24391(2-chloro-N-[1-(3-hydroxypropyl)-2-oxo-1,2,3,4-tetr...)
Affinity DataIC50:  21nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24398(2-chloro-N-[(3R)-1-[(2S)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50:  21nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194420((S)-2,3-dibromo-N-(1-(dimethylamino)-1-oxo-3-pheny...)
Affinity DataIC50:  23nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385403(CHEMBL2036574)
Affinity DataIC50:  23nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24386(2-chloro-N-[1-(2-hydroxyethyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50:  26nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24397(2-chloro-N-[(3S)-1-[(2R)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50:  27nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24384(2-chloro-N-[1-(cyanomethyl)-2-oxo-1,2,3,4-tetrahyd...)
Affinity DataIC50:  28nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24394(2-chloro-N-{1-[(2R)-2,3-dihydroxypropyl]-2-oxo-1,2...)
Affinity DataIC50:  29nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320326(2-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  30nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194417((S)-2-bromo-N-(1-(dimethylamino)-1-oxo-3-phenylpro...)
Affinity DataIC50:  31nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385423(CHEMBL2036595)
Affinity DataIC50:  32nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetDiacylglycerol O-acyltransferase 1(Homo sapiens (Human))
Astrazeneca

Curated by ChEMBL
LigandPNGBDBM50385440(CHEMBL2036729)
Affinity DataIC50:  35nMAssay Description:Inhibition of human recombinant DGAT1 expressed in baculovirus infected insect sf9 cells using [14C] oleoyl coenzyme A after 30 mins by scintillation...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24388(2,3-dichloro-N-{1-[3-hydroxy-2-(hydroxymethyl)prop...)
Affinity DataIC50:  38nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24396(2-chloro-N-[(3R)-1-[(2R)-2,3-dihydroxypropyl]-2-ox...)
Affinity DataIC50:  40nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320328(2-(((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrol...)
Affinity DataIC50:  40nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320317(2-((1R,2R)-2-(2-chloro-6H-thieno[2,3-b]pyrrole-5-c...)
Affinity DataIC50:  40nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24363(2-chloro-N-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)...)
Affinity DataIC50:  41nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24363(2-chloro-N-(2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)...)
Affinity DataIC50:  41nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320329(4-(((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrol...)
Affinity DataIC50:  42nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24395(3,4-dihydro-2-quinolone (DHQ) derivative, 34 | 5-c...)
Affinity DataIC50:  44nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24392(2-chloro-N-[1-(2-hydroxybutyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50:  44nMAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24367(2-chloro-N-[1-(2-methanesulfinylethyl)-2-oxo-1,2,3...)
Affinity DataIC50:  48nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50194410(2,3-dichloro-N-((1R,2R)-6-fluoro-1-hydroxy-2,3-dih...)
Affinity DataIC50:  49nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM24365(2-chloro-N-[1-(2-methoxyethyl)-2-oxo-1,2,3,4-tetra...)
Affinity DataIC50:  50nMpH: 7.2 T: 2°CAssay Description:The inhibitory activity of the test compounds against human recombinant glycogen phosphorylase a (GPa) was monitored using 96-well microplate format....More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50065954((S)-5-chloro-N-(1-(dimethylamino)-1-oxo-3-phenylpr...)
Affinity DataIC50:  51nMAssay Description:Inhibition of recombinant human liver GPa by multienzyme coupled assayMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320319(2-((1R,2R)-2-(5-chloro-7-fluoro-1H-indole-2-carbox...)
Affinity DataIC50:  52nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320325(4-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  54nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320324(3-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  56nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320330(3-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  56nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320315(2-((1R,2R)-2-(5-chloro-1H-indole-2-carboxamido)-2,...)
Affinity DataIC50:  57nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetGlycogen phosphorylase, liver form(Homo sapiens (Human))
Astrazeneca

LigandPNGBDBM50320327(3-((1R,2R)-2-(2,3-dichloro-4H-thieno[3,2-b]pyrrole...)
Affinity DataIC50:  59nMAssay Description:Inhibition of human recombinant liver glycogen phosphorylase by multienzyme-coupled reactionMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
Displayed 1 to 50 (of 135 total ) | Next | Last >>
Jump to: